Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 8 of 8 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EPRATUZUMAB (D04036) | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
(D04036) 💬1. EPRATUZUMAB
| 1件: CD22 CD22 💬1. EPRATUZUMAB
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬1. EPRATUZUMAB
| ||||||||||||||
| 2 | Epratuzumab 100 mg (D04036) | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
(D04036) 💬2. Epratuzumab 100 mg
| 1件: CD22 CD22 💬2. Epratuzumab 100 mg
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬2. Epratuzumab 100 mg
| ||||||||||||||
| 3 | Epratuzumab 1200 mg (D04036) | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
(D04036) 💬3. Epratuzumab 1200 mg
| 1件: CD22 CD22 💬3. Epratuzumab 1200 mg
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬3. Epratuzumab 1200 mg
| ||||||||||||||
| 4 | Epratuzumab 400 mg (D04036) | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
(D04036) 💬4. Epratuzumab 400 mg
| 1件: CD22 CD22 💬4. Epratuzumab 400 mg
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬4. Epratuzumab 400 mg
| ||||||||||||||
| 5 | Epratuzumab 600 mg (D04036) | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
(D04036) 💬5. Epratuzumab 600 mg
| 1件: CD22 CD22 💬5. Epratuzumab 600 mg
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬5. Epratuzumab 600 mg
| ||||||||||||||
| 6 | Epratuzumab iv (D04036) | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
(D04036) 💬6. Epratuzumab iv
| 1件: CD22 CD22 💬6. Epratuzumab iv
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬6. Epratuzumab iv
| ||||||||||||||
| 7 | Epratuzumab sc (D04036) | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
(D04036) 💬7. Epratuzumab sc
| 1件: CD22 CD22 💬7. Epratuzumab sc
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬7. Epratuzumab sc
| ||||||||||||||
| 8 | HLL2 (Epratuzumab) (D04036) | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
(D04036) 💬8. HLL2 (Epratuzumab)
| 1件: CD22 CD22 💬8. HLL2 (Epratuzumab)
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬8. HLL2 (Epratuzumab)
|